Arnt V. Kristen

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

David Adams, Alejandra González‐Duarte, William O’Riordan et al. · New England Journal of Medicine · 2018 · 2.9K citations · Full text

Life Sciences, Molecular Biology, Pharmacology +14

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

Jeffrey H. Schwartz, Balarama Gundapaneni, Perry Elliott et al. · New England Journal of Medicine · 2018 · 2.7K citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

Pablo García‐Pavía, Claudio Rapezzi, Yehuda Adler et al. · European Heart Journal · 2021 · 1.1K citations · Full text

Medicine, Cardiology, Pathology +16

Genotype and Phenotype of Transthyretin Cardiac Amyloidosis

Mathew S. Maurer, Mazen Hanna, Martha Grogan et al. · Journal of the American College of Cardiology · 2016 · 534 citations · Full text

Medicine, Cardiology, Genetics +12

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2—evidence base and standardized methods of imaging

Sharmila Dorbala, Sabahat Bokhari, Angela Dispenzieri et al. · Journal of Nuclear Cardiology · 2019 · 475 citations · Full text

Medicine, Cardiology, Radiology +17